Effects of probabilities, adverse outcomes, and status quo on perceived riskiness of medications: Testing explanatory hypotheses concerning gist, worry, and numeracy

We tested predictions of fuzzy-trace theory that qualitative health status and gist representations (ordinal and categorical) of risks contribute to willingness to start medications, beyond effects of objective risk, emotion (worry), and numeracy. Adults in two experiments were given hypothetical sc...

Full description

Bibliographic Details
Main Authors: Fraenkel, L. (Author), Reyna, V.F (Author), Wilhelms, E.A (Author)
Format: Article
Language:English
Published: John Wiley and Sons Ltd 2018
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02758nam a2200565Ia 4500
001 10.1002-acp.3448
008 220706s2018 CNT 000 0 und d
020 |a 08884080 (ISSN) 
245 1 0 |a Effects of probabilities, adverse outcomes, and status quo on perceived riskiness of medications: Testing explanatory hypotheses concerning gist, worry, and numeracy 
260 0 |b John Wiley and Sons Ltd  |c 2018 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/acp.3448 
520 3 |a We tested predictions of fuzzy-trace theory that qualitative health status and gist representations (ordinal and categorical) of risks contribute to willingness to start medications, beyond effects of objective risk, emotion (worry), and numeracy. Adults in two experiments were given hypothetical scenarios based on actual medications, varying health status quo (acceptable or unacceptable), adverse event (pneumonia or cancer), and four levels of quantitative risk (from 1/100,000 to 1/100) between subjects. In both experiments, cancer and higher quantitative risk elicited greater worry and risk perceptions and reduced willingness to start a new medication. Willingness to start was also influenced by health status quo. After controlling for other variables, only status quo and gist representations consistently predicted willingness to start in both experiments. Results support an integrated approach to understanding and predicting perceptions of the risks of medications that encompasses numerical cognition, emotions (such as worry), and qualitative gist representations of medical information. © 2018 John Wiley & Sons, Ltd. 
650 0 4 |a adult 
650 0 4 |a adverse outcome 
650 0 4 |a Article 
650 0 4 |a cognition 
650 0 4 |a controlled study 
650 0 4 |a emotion 
650 0 4 |a female 
650 0 4 |a fuzzy trace theory 
650 0 4 |a fuzzy-trace theory 
650 0 4 |a gist 
650 0 4 |a health status 
650 0 4 |a human 
650 0 4 |a hypothesis 
650 0 4 |a male 
650 0 4 |a malignant neoplasm 
650 0 4 |a medical information 
650 0 4 |a medication compliance 
650 0 4 |a numeracy 
650 0 4 |a patient attitude 
650 0 4 |a patient risk 
650 0 4 |a patient worry 
650 0 4 |a perception 
650 0 4 |a pneumonia 
650 0 4 |a prediction 
650 0 4 |a priority journal 
650 0 4 |a probability 
650 0 4 |a qualitative analysis 
650 0 4 |a qualitative research 
650 0 4 |a quantitative analysis 
650 0 4 |a risk assessment 
650 0 4 |a risk communication 
650 0 4 |a risk factor 
650 0 4 |a side effects 
650 0 4 |a theory 
700 1 |a Fraenkel, L.  |e author 
700 1 |a Reyna, V.F.  |e author 
700 1 |a Wilhelms, E.A.  |e author 
773 |t Applied Cognitive Psychology